AKT1 and hepatocellular carcinoma: In this study, we found that Girdin silencing in hepatocellular carcinoma cells significantly inhibited the PI3K-Akt signaling pathway, suggesting that the PI3K-Akt signaling pathway mediates the regulatory effect of Girdin on hepatocellular carcinoma progression.